Skip to main content

BIO-TECHNE Corp revenue

  • TECH · Nasdaq
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$72.80−0.05%Close 13 Nov 2026

BIO-TECHNE Corp's revenue was $1.22 billion for fiscal year 2026 (the twelve months to 30 Jun 2026), down 0.4% from fiscal 2025.

In the first quarter of fiscal 2027 (the three months to 30 Sep 2026) it was $300 million, up 4.6% from a year earlier.

Over the four quarters to 30 Sep 2026, revenue was $1.23 billion.

From BIO-TECHNE Corp's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 6 Nov 2026.

Fiscal 2026
$1.22B
−0.4%
Q1 FY2027
$300M
+4.6% on a year
Growth over 9 years
+8.9%
a year, FY 2017–FY 2026

Revenue by fiscal year

$563MFY 2017$643MFY 2018+14.2%$714MFY 2019+11.0%$739MFY 2020+3.5%$931MFY 2021+26.0%$1.11BFY 2022+18.7%$1.14BFY 2023+2.8%$1.16BFY 2024+2.0%$1.22BFY 2025+5.2%$1.22BFY 2026−0.4%

Change on the year before, under each year. From FY 2017 to FY 2026, BIO-TECHNE Corp's revenue went from $563 million to $1.22 billion, a compound annual change of +8.9%; the highest was $1.22 billion in FY 2025.

BIO-TECHNE Corp revenue, fiscal years
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Revenue$563M$643M$714M$739M$931M$1.11B$1.14B$1.16B$1.22B$1.22B
Period end30 Jun 201730 Jun 201830 Jun 201930 Jun 202030 Jun 202130 Jun 202230 Jun 202330 Jun 202430 Jun 202530 Jun 2026

Revenue by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

BIO-TECHNE Corp revenue, fiscal quarters
PeriodQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue$297M$316M$317M$287M$296M$311M$321M$300M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How revenue is measured

Revenue is the total amount a company earns from its sales of goods and services in a period, before any cost is deducted, as reported on its income statement. For banks it is net revenue: net interest income plus fees and other income. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

BIO-TECHNE Corp's other figures

Revenue of comparable companies

Everything on TECH, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.